EVERSION Technologies GmbH
Germany DE-MF-000048231 Last updated 21 Oct 2026
Is this your brand? Sign in to claim this brand
- Devices
- 18
- Registries
- EUDAMED
- FDA recalls
- 0
Catalogue
0°-Sohle Ref ZERO - 41
0°-Sohle Ref ZERO - 39
0°-Sohle Ref ZERO - 47
0°-Sohle Ref ZERO - AS - 45
0°-Sohle Ref ZERO - 46
Zero - As Ref ZERO - AS - 37
0°-Sohle Ref ZERO - 36
0°-Sohle Ref ZERO - AS - 41
0°-Sohle Ref ZERO - AS - 38
0°-Sohle Ref ZERO - AS - 47
0°-Sohle Ref ZERO - AS - 44
Inga - As Ref INGA - AS - 36
0°-Sohle - 43 Ref 0°-Sohle
Inga Ref INGA - 42
0°-Sohle Ref 0°-Sohle - 37
Inga Ref INGA - 36
Inga Ref INGA - 38
Inga Ref INGA - 43
Zero - 45 Ref 0°-Sohle
Inga Ref INGA - AS - 36
Inga Ref INGA - 42
Inga Ref INGA - AS - 47
Inga Ref INGA - 41
Inga Ref INGA - AS - 38
Inga Ref INGA - AS - 45
Inga Ref INGA - AS - 37
Inga Ref INGA - 39
Inga Ref INGA - 43
Inga Ref INGA - 45
About
With the gait analysis of EVERSION, measure permanent deformities in everyday life with the app and the sensor soles in order to understand the causes of pain in the musculoskeletal system and to compensate individually with the 0° sole. Do something good and relieve your complaints.
What EVERSION Technologies GmbH makes
EVERSION Technologies GmbH manufactures wearable sensor-based insoles called INGA, designed for gait analysis. These devices track foot movement and biomechanics in real-world conditions to assess musculoskeletal deformities and identify sources of pain. The soles integrate with a companion app to provide data-driven insights for personalized compensation strategies, such as adjusting foot positioning with a 0° sole.
The INGA insoles are classified as Class I medical devices under EU regulations and are registered in the EUDAMED database. The company is based in Germany, adhering to EU medical device compliance requirements for non-invasive, low-risk diagnostic and monitoring tools.
Frequently asked questions
What types of medical devices does EVERSION Technologies GmbH manufacture?
EVERSION Technologies GmbH specializes in wearable medical devices called INGA, which are sensor-based insoles. These devices are designed for gait analysis, allowing users to measure foot movement and biomechanics in everyday life through real-time data collection. The primary purpose is to help identify musculoskeletal deformities and potential causes of pain, enabling personalized interventions like adjustments with a 0° sole.
Where is EVERSION Technologies GmbH based, and what regulatory requirements does it follow?
EVERSION Technologies GmbH is based in Germany, where it operates under EU medical device regulations. Since its devices are classified as Class I, they are subject to the EU’s general medical device safety and performance requirements, including mandatory registration in EUDAMED. This classification applies because the devices are non-invasive, low-risk tools for diagnostic and monitoring purposes.
Are EVERSION Technologies GmbH’s devices listed in any regulatory registries?
Yes, EVERSION Technologies GmbH’s devices are registered in the EUDAMED database, which is the official European Union registry for medical devices. This listing ensures transparency and compliance with EU regulations, particularly for Class I devices, which must be documented to demonstrate adherence to safety and performance standards.
How are EVERSION Technologies GmbH’s devices classified under EU regulations?
EVERSION Technologies GmbH’s INGA insoles are classified as Class I medical devices under EU regulations. This classification is determined by their intended use—non-invasive, low-risk diagnostic and monitoring tools for gait analysis—and their minimal risk profile. Class I devices typically require basic conformity assessment procedures, such as self-certification by the manufacturer, to demonstrate compliance with EU safety and performance standards.
Information
- Country
- Germany
- Address
- 3, Bücklestraße, Konstanz, Germany
- Website
- www.eversion.tech
- linkedin.com/company/eversion
- facebook.com/100081269566797
- [email protected]
- PRRC contact
- Timon Sutter
- EUDAMED SRN
- DE-MF-000048231